Nuclear Receptor Coactivator 2 Promotes Human Breast Cancer Cell Growth by Positively Regulating the MAPK/ERK Pathway

Nuclear Receptor Coactivator 2 Promotes Human Breast Cancer Cell Growth by Positively Regulating the MAPK/ERK Pathway

As a member of the p160 steroid receptor coactivator (SRC) family, nuclear receptor coactivator 2 (NCOA2) is known to play essential roles in many physiological and pathological processes, including development, endocrine regulation, and tumorigenesis. However, the biological function of NCOA2 in br...

Full description

Bibliographic Details
Main Authors: Mengjiao Cai, Xin Liang, Xiao Sun, Huan Chen, Yiping Dong, Lingzhi Wu, Suxi Gu, Suxia Han
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-03-01
Series:Frontiers in Oncology
Subjects:
NCOA2
breast cancer
RASEF
MAPK/ERK
therapeutic target
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.00164/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.00164/full

Similar Items